Skip to main content
SpringerLink
Log in

Plötzlicher Herztod und hypertensive Herzkrankheit

  • Conference paper
Endorganschädigungen der arteriellen Hypertonie — Konsequenzen für Diagnostik und Therapie

  • 21 Accesses

Zusammenfassung

Um die Morbidität und Mortalität von Herz-Kreislauf-Erkrankungen zu senken, ist die Identifizierung möglichst aller Risikofaktoren des kardiovaskulären Systems unerläßlich. In mehreren prospektiven Untersuchungen wurde die pathogenetische Relevanz von arterieller Hypertonie, Hyperlipidämien, Diabetes mellitus, Nikotinkonsum und Adipositas bestätigt. Hingegen ist die linksventrikuläre Hypertrophie (LVH) als potentieller Risikofaktor für Herz-Kreislauf-Erkrankungen lange Zeit nicht beachtet worden, da sie bei Patienten mit arterieller Hypertonie als chronische Anpassung an die Nachlasterhöhung im systemischen Kreislauf und damit als ein physiologischer kompensatorischer Prozeß angesehen wurde. Zahlreiche prospektive Untersuchungen konnten jedoch nachweisen, daß die LVH ein eigenständiger und insbesondere von der arteriellen Hypertonie unabhängiger Risikofaktor für die Morbidität und Mortalität von Herz-Kreislauf-Erkrankungen ist.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Arntz HR, Storch WH, Schröder R (1990) Bekämpfung des plötzlichen Herztodes. Dtsch Ärztebl 87: 1341–1343

    Google Scholar 

  2. Aronow WS, Epstein S, Koenigsberg M, Schwartz KS (1988) Usefulness of echocardiography left ventricular hypertrophy, ventricular tachycardia and complex ventricular arrhythmias in predicting ventricular fibrillation or sudden cardiac death in elderly patients. Am J Cardiol 62: 1124–1125

    Article  PubMed  CAS  Google Scholar 

  3. Aronow WS, Koenigsberg M, Schwartz KS (1988) Usefulness of echocardiographic left ventricular hypertrophy in predicting new coronary events and artherothrombotic brain infarction in patients over 62 years of age. Am J Cardiol 621: 1130–1132

    Article  Google Scholar 

  4. Breslin DJ, Gifford RW Jr, Fairbain JF II (1966) Essential hypertension: a twenty-year follow-up study. Circulation 33: 87–97

    PubMed  CAS  Google Scholar 

  5. Brush JE, Cannon RD, Schenke WH, Bonow RO, Leon MB, Maron BJ, Epstein SE (1988) Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 319: 1302–1307

    Article  PubMed  Google Scholar 

  6. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, Laragh JH (1986) Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Int Med 105: 173–178

    PubMed  CAS  Google Scholar 

  7. Clementy J, Safar M, Vrancea F (1989) Cardiac arrhythmias in hypertension. Prospective study including 251 patients. Efficacy of Sotalol. Eur Heart J [Suppl] 10: 201 (abstract)

    Google Scholar 

  8. Dickhuth HH, Reindell H, Lehmann M, Keul J (1985) Rückbildungsfähigkeit des Sportherzens. Z Kardiol [Suppl7] 74: 135–143

    Google Scholar 

  9. Drayer JIM, Gardin JM, Weber MA, Aronow WS (1983) Cardiac muscle mass during vasodilation therapy of hypertension. Clin Pharmacol Ther 33: 727–732

    Article  PubMed  CAS  Google Scholar 

  10. Dunn FG, Ventura HO, Messerli FH, Kobrin I, Fröhlich ED (1987) Time course of regression of left ventricular hypertrophy in hypertensive patients treated with atenolol. Circulation 76 2: 254–258

    Article  PubMed  CAS  Google Scholar 

  11. Fouad FM, Nakashima Y, Tarazi RC, Salcedo EE (1982) Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa: Lack of association with blood pressure control. Am J Cardiol 49: 795–801

    Google Scholar 

  12. Garavaglia GE, Messerli FH, Nunez BD, Schmieder RE, Fröhlich ED (1988) All angiotensin Converting enzyme (ACE) Inhibitors are not alike: disparities in the mechanism of the antihypertensive effect. AJH 1: 2145–2165

    Google Scholar 

  13. Gleichmann U, Brauns N, Mannebach N, Bogunovic N, Seggewiss H (1986) Hypertensive Herzkrankheit bei milder Hypertonie. MMW 128: 844–849

    Google Scholar 

  14. Granger CB, Kazimeddini MK, Smith VE et al. (1985) Rapid ventricular filling in left ventricular hypertrophy: physiological hypertrophy. JACC 5: 862–874

    PubMed  CAS  Google Scholar 

  15. Hauser AM, Dressendorfer RH, Vos M, Hashimoto T, Gordon S, Timmis GC (1985) Symmetrie cardiac enlargement in highly trained endurance athletes: a two-dimensional echocardiographic study. Am Heart J 109: 1038–1044

    Article  PubMed  CAS  Google Scholar 

  16. Heagerty AM, Bund SJ, Aalkjaer C (1988) Effects of drug treatment on human resistance arteriole morphology in essential hypertension: direct evidence for structural remodelling of resistance vessels. Lancet II: 1201

    Google Scholar 

  17. Ikaeheimo MJ, Palatsi IJ, Takkunen JT (1979) Noninvasive evaluation of the athletic heart: sprinters versus endurance runners. Am J Cardiol 44: 24–30

    Article  Google Scholar 

  18. Inon T, lamberth WCJ, Koyonagi S (1987) Relative importance of hypertension after coronary occlusion in chronic hypertensive dogs with LVH. Am J Physiol 253: H1148 - H1158

    Google Scholar 

  19. Juul-Möller S, Hedblad BO, Svensson et al. (1989) Prognostic information carried by ST-segment depressions and arrhythmias in a cohort from a general population. Circulation [Söuppl II] 80: 615

    Article  Google Scholar 

  20. Kannel WB (1983) Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med [Suppl 3A] 75: 4–11

    Article  CAS  Google Scholar 

  21. Kannel WB, Gordon T, Olfit D (1969) Left ventricular hypertrophy by ECG. Prevalence, incidence and mortality in the Framingham Study. Ann Intern Med 71: 89–97

    Google Scholar 

  22. Kannel WB, D’Agostino RB, Levy D, Belanger AJ (1988) Prognostic significance of regression of left ventricular hypertrophy. Circulation [Suppl II] 78: 89

    Google Scholar 

  23. Kannel WB, Gordon T, Castelli WP, Margolis JR (1970) Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. Ann Int Med 72: 813–822

    PubMed  CAS  Google Scholar 

  24. Koren MJ, Casale PN, Savage DD, Laragh JH, Devereux RB (1989) Relation of left ventricular mass to prognosis in essential hypertension. Circulation [Suppl II] 80: 538 (abstract)

    Google Scholar 

  25. Koyogani S, Eastham CL, Harrison DG, Marcus ML (1982) Increased size of myocardial infraction in dogs with chronic hypertension and left ventricular hypertrophy. Circ Res 50: 55–62

    Google Scholar 

  26. Krayenbuehl HP (1982) Ist die sekundäre Myokardhypertrophie ein physiologischer oder pathologischer Adaptationsmechanismus? Z Kardiol 71: 489–496

    Google Scholar 

  27. Le Henzey JY, Guize L (1988) Cardiac prognosis in hypertensive patients. Incidence of sudden death and ventricular arrhythmias. Am JMed [Suppl IB] 84: 65–68

    Google Scholar 

  28. Levy D, Anderson KM, Christiansen JC, Campanile G, Stokes J III (1988) Antihypertensive drug therapy and arrhythmia risk. Am J Cardiol 62: 1

    Google Scholar 

  29. Levy D, Anderson KM, Savage DD, Balkus SA, Kannel WB, Castelli WP (1987) Risk of ventricular arrhythmias in left ventricuar hypertrophy. The Framingham Heart Study. Am J Cardiol 60: 560–565

    Google Scholar 

  30. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1989) Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann Int Med 110: 101–107

    Google Scholar 

  31. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl JMed 322: 1561–1565

    Article  CAS  Google Scholar 

  32. Lown B, Temte JV, Reich PR, Gaughan G, Regestein Q, Hai H (1976) Basis for recurring: ventricular fibrillation in the absence of coronary heart disease and its magement. N Engl J Med 294: 623–629

    Article  PubMed  CAS  Google Scholar 

  33. Mace PJE, Littler WA, Glover DR, Rowlands DB, Stallard TJ (1985) Regression of left ventricular hypertrophy in hypertension. Comparative effects of three different drugs. J Cardiovasc Pharmacol [Suppl] 7: 52–55

    Google Scholar 

  34. Marcus ML, Harrison DG, Chilian WM et al. (1987) Alterations in the coronary circulation in hypertrophied ventricles. Circulation [Suppl I] 75: 19–25

    Google Scholar 

  35. Boden WE, Kleiger RE, Schechtman KB, Copone RL, Schwartz DJ, Gibson RS (1988) Clinical significance and prognostic importance of left ventricular hypertrophy in non-Q-wave acute myocardial in infarction. Am J Cardiol 62: 1000–1004

    Article  PubMed  CAS  Google Scholar 

  36. Maron BJ, Roberts WC, McAllister HA, Rösing DR, Epstein SE (1980) Sudden death in young athletes. Circulation 62 2: 218–229

    PubMed  CAS  Google Scholar 

  37. McLenachan JM, Henderson E, Morris KI, Dargie HJ (1987) Ventricular arrhythmias in I patients with hypertensive left ventricular hypertrophy. N Engl J Med 317: 787–792

    Article  PubMed  CAS  Google Scholar 

  38. Messerli FH, Nunez BD, Nunez MM, Garavaglia GE, Schmieder RE, Ventura HO (1989) Hypertension and sudden death. Disparate effects of calcium entry blockers and diuretic therapy on cardiac dysrhythmias. Arch Intern Med 149: 1263–1267

    Google Scholar 

  39. Messerli FH, Nunez BD, Ventura HO, Snyder DW (1988) Overweight and sudden death: Increased ventricular ectopy in cardiopathy of obesity. Arch Intern Med 147: 1725–1728

    Google Scholar 

  40. Messerli FH, Schmieder R (1986) Left ventricular hypertrophy — a cardiovascular risk factor in essential hypertension. Drugs [Suppl IV] 31: 192–197

    Article  Google Scholar 

  41. Messerli Fh, Ventura HO, Elizardi DJ, Dunn FG, Fröhlich ED (1984) Hypertension and sudden death: Increased ventricular ectopy activity in left ventricular hypertrophy. Am J Med 77: 18–22

    Google Scholar 

  42. Nishimura T, Yamada Y, Kawai C (1980) Echocardiographic evaluation of long-term effects of % exercise of left ventricular hypertrophy and function in professional bicyclists. Circulation J 61: 832–840

    CAS  Google Scholar 

  43. Nunez BD, Messerli FH, Garavaglia GE, Schmieder RE (1987) Exaggerated atrial and ventricular excitability in hypertensive patients with isolated septal hypertrophy ( ISH ). J Am Coli Cardiol 9: 225A

    Google Scholar 

  44. Roeske W, O’Rourke RA, Klein A, Leopold G, Karliner JS (1976) Noninvasive evaluation of ventricular hypertrophy in professional athletes. Circulation 53: 286–293

    PubMed  CAS  Google Scholar 

  45. Schmieder RE, Nunez BD, Messerli FH (in preparation) Determinants of ventricular ectopy in hypertensive heart disease.

    Google Scholar 

  46. Schmieder RE, Rüddel H, Grube E, Schulte W (1988) Depressed myocardial contractility in early left ventricular hypertrophy. Circulation [Suppl II] 78: 75

    Google Scholar 

  47. Seipel L, Breithardt G (1984) Plötzlicher Herztod. In: Roskamm H (Hrsg) Koronarerkrankungen. Springer, Berlin Heidelberg New York Tokyo (Handbuch der inneren Medizin, Bd 9/3: S835

    Google Scholar 

  48. Sideris DA, Kontoyannis DA, Michaiis L, Adractas A, Moulopoulos SD (1987) Acute changes in blood pressure as a cause of cardiac arrhythmias. Eur Heart J 8: 45–52

    PubMed  CAS  Google Scholar 

  49. Smith VE, Schulman P, Karimeddini MK, White WB, Meeran MK, Katz AM (1984) Rapid ventricular filling in left ventricular hypertrophy. II. Pathologie hypertrophy. JACC 5: 869–874

    Google Scholar 

  50. Sokolow M, Perloff D (1961) The prognosis of essential hypertension treated conservatively. Circulation 23: 697–713

    Google Scholar 

  51. Strauer BE (1979) Ventricular funetions and coronary hemodynamics in hypertensive heart disease. Am J Cardiol 44: 999–1006

    Article  PubMed  CAS  Google Scholar 

  52. Toyoshima H, Park YG, Ishikawa Y (1982) Effects of ventricular hypertrophy on conduction velocity of activation front in the ventricular myocardium. Am J Cardiol 49: 1938–1945

    Article  PubMed  CAS  Google Scholar 

  53. Tubau JF, Szlachcic J, Braun S, Massie BM (1989) Impaired left ventricular functional reserve in hypertensive patients with left ventricular hypertrophy. Hypertension 14: 1–8

    PubMed  CAS  Google Scholar 

  54. Virmani R, Robinowitz M, McAllister HA Jr (1982) Nontraumatic death in joggers. A series of 30 patients at autopsy. Am J Med 72: 874–882

    Article  PubMed  CAS  Google Scholar 

  55. White CW, Mirro MJ, Lund DD, Skorton DJ, Pandian NG, Kerber RE (1986) Alterations in ventricular excitability in conscious dogs during the development of chronic heart failure. Am J Physiol 250: H 1022–1029

    Google Scholar 

Download references

Authors
  1. F. H. Messerli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. E. Schmieder
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. 4. Med. Klinik, Universität Erlangen-Nürnberg, Kontumazgarten 14-18, D-8500, Nürnberg 80, Germany

    Roland E. Schmieder

  2. Nibelungenstraße 9a, D-8000, München 19, Germany

    Hans-Michael Müller

  3. Section of Hypertension, Ochsner Clinic, 1514 Jefferson Highway, 70121, New Orleans, LA, USA

    Franz H. Messerli

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Messerli, F.H., Schmieder, R.E. (1991). Plötzlicher Herztod und hypertensive Herzkrankheit. In: Schmieder, R.E., Müller, HM., Messerli, F.H. (eds) Endorganschädigungen der arteriellen Hypertonie — Konsequenzen für Diagnostik und Therapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76361-8_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76361-8_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-53581-2

  • Online ISBN: 978-3-642-76361-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation